Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
273
NCT07192588
A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 26, 2024
Completion: Oct 30, 2026